As this video ran longer than I had anticipated, I’ll sum up my thoughts for those that don’t have the time or inclination to watch the entire video. Despite the fact that the biotech sector has been drifting higher in a choppy but overall bullish trading range since the February lows, there is very little, if any, evidence on the long-term charts that indicates the bear market off the July 2015 highs is over. The biotechs very well could be on their way to new highs but again, the technical evidence to support that case just isn’t there yet, although it could be very soon should the sector continue much higher.

Zooming down to the daily charts, many of the top components of the biotechs have been moving higher following bullish chart developments with most now approaching significant resistance levels which, if clearly taken out, would be bullish but those same levels could also offer objective shorting opportunities if the recent gains in the sector is simply a bear market rally in its latter stages.

The video starts off with discussion of the broad markets & how that will likely determine the next major trend in the biotechs, followed by an overview of XBI (SPDR S&P Biotech ETF) as well as a detailed look at the charts of the top 10 components of the sector. Key technical levels, including some potential price targets on many of these stocks or ETFs are included.